Skip to content
10-Q

Quarterly Report

Zentalis Pharmaceuticals, Inc. ZNTL

0001725160-25-000149

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 72.14M sh
Shares Diluted Q2 2025 · Jun 30, 2025 71.99M sh
Shares Diluted Q2 2025 · Jun 30, 2025 71.84M sh
Shares Diluted Q2 2025 · Jun 30, 2024 71.04M sh
Shares Diluted Q2 2025 · Jun 30, 2024 70.97M sh
Capex Q2 2025 · Jun 30, 2025 $0
Capex Q2 2025 · Jun 30, 2024 $221K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$67.34M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$87.11M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $37.6M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $33.9M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $36.98M
Stockholders Equity Q2 2025 · Jun 30, 2025 $274.5M
Stockholders Equity Q2 2025 · Dec 31, 2024 $337.19M
Current Liabilities Q2 2025 · Jun 30, 2025 $39.02M
Current Liabilities Q2 2025 · Dec 31, 2024 $52.73M
Total Liabilities Q2 2025 · Jun 30, 2025 $77.21M
Total Liabilities Q2 2025 · Dec 31, 2024 $93.15M
Current Assets Q2 2025 · Jun 30, 2025 $311.6M
Current Assets Q2 2025 · Dec 31, 2024 $386.07M
Total Assets Q2 2025 · Jun 30, 2025 $351.71M
Total Assets Q2 2025 · Dec 31, 2024 $430.34M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.37
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.05
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.24
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.10
Eps Basic Q2 2025 · Jun 30, 2025 −$0.37
Eps Basic Q2 2025 · Jun 30, 2025 −$1.05
Eps Basic Q2 2025 · Jun 30, 2024 −$1.24
Eps Basic Q2 2025 · Jun 30, 2024 −$1.10
Sga Expense Q2 2025 · Jun 30, 2025 $8.45M
Sga Expense Q2 2025 · Jun 30, 2025 $19.03M
Sga Expense Q2 2025 · Jun 30, 2024 $16.76M
Sga Expense Q2 2025 · Jun 30, 2024 $32.5M
Rd Expense Q2 2025 · Jun 30, 2025 $27.61M
Rd Expense Q2 2025 · Jun 30, 2025 $54.86M
Rd Expense Q2 2025 · Jun 30, 2024 $48.39M
Rd Expense Q2 2025 · Jun 30, 2024 $97.97M
Net Income Q2 2025 · Jun 30, 2025 −$26.87M
Net Income Q2 2025 · Jun 30, 2025 −$75.15M
Net Income Q2 2025 · Jun 30, 2024 −$88.28M
Net Income Q2 2025 · Jun 30, 2024 −$78.21M
Operating Income Q2 2025 · Jun 30, 2025 −$36.06M
Operating Income Q2 2025 · Jun 30, 2025 −$81.68M
Operating Income Q2 2025 · Jun 30, 2024 −$65.15M
Operating Income Q2 2025 · Jun 30, 2024 −$89.91M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2024 $40.56M